We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
SPEC | Spectaire Holdings Inc | 0.7001 | 0.27165 | 63.40% | 1,515,700 |
SLRX | Salarius Pharmaceuticals Inc | 0.475 | 0.064 | 15.57% | 250 |
TRNR | Interactive Strength Inc | 0.1432 | 0.0134 | 10.32% | 38,331 |
UONE | Urban One Inc | 2.34 | 0.205 | 9.60% | 150 |
ELVN | Enliven Therapeutics Inc | 22.78 | 1.84 | 8.79% | 6,606 |
JTAI | Jet AI Inc | 0.626 | 0.0457 | 7.87% | 501 |
HUGE | FSD Pharma Inc | 0.2469 | 0.0169 | 7.35% | 1,065 |
FBRX | Forte Biosciences Inc | 0.62 | 0.0369 | 6.33% | 279 |
AMIX | Autonomix Medical Inc | 1.43 | 0.08 | 5.93% | 3,003 |
BACK | IMAC Holdings Inc | 2.59 | 0.14 | 5.71% | 124 |
HPCO | Hempacco Company Inc | 0.95 | 0.05 | 5.56% | 100 |
After two decades of successfully scaling multiple healthcare companies, Steven Nelson joins DarioHealth as Chief Commercial Officer to accelerate revenue growth across the health plans, employers and pharma channels NEW YORK, June 5, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario", "DarioHealth" or the "Company"), a leader in the global digital health market, announced today a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. This move reflects the Company's commitment to bringing its innovative solutions to the market faster, maximizing customer impact, and driving the organization to profitability.
SHANGHAI, June 7, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today announced that it has achieved a significant breakthrough in its egg business following the Company stepping into the egg industry.
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was notified by the Nasdaq Stock Market LLC (“Nasdaq”) that the Company had regained compliance with the stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (“Minimum Equity Requirement”). Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company will be subject to a mandatory panel monitor through June 4, 2025. The Nasdaq Staff originally issued the Company a deficiency notice on May 31, 2023, citing that stockholders’ ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the Truist Securities MedTech Conference, which is being held at the InterContinental Boston in Boston, MA on Tuesday, June 18th. Management will participate in 1x1 meetings. There will be no formal presentation. About Organogenesis Holdings Inc. Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 68,981.83 | -1,782.19 | -2.52% | 1.36T | 4,073,900,108 |
ETH | Ethereum | 3,673.18 | -138.09 | -3.62% | 441.15B | 1,864,114,206 |
BNB | Binance Coin | 680.33 | -30.14 | -4.24% | 107.06B | 387,866,006 |
USDT | Tether USD | 0.99958 | -0.00003 | 0.00% | 97.79B | 253,593,931 |
SOL | Solana | 161.96 | -7.99 | -4.70% | 71.01B | 698,277,731 |
STETH | stETH | 3,672.89 | -136.10 | -3.57% | 35.88B | 5,829,888 |
USDC | USD Coin | 0.9999 | 0.0001 | 0.01% | 28.07B | 829,235,398 |
XRP | Ripple | 0.4953 | -0.0261 | -5.01% | 26.92B | 259,764,482 |
TONCOIN | Wrapped TON Coin | 7.20 | -0.294609 | -3.93% | 25.03B | 184,899,027 |
DOGE | Dogecoin | 0.148 | -0.01203 | -7.52% | 21.13B | 231,113,247 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions